Imaging biomarkers and staging in IPF

Current Opinion in Pulmonary Medicine

Volumn 24, Issue 5, 2018, Pages 445-452

  Walsh, Simon L F ^a  

^a KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

High resolution computed tomography (HRCT); Idiopathic pulmonary fibrosis; Quantitative computed tomography; Semiquantitative HRCT analysis

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FIBROSING ALVEOLITIS; HIGH RESOLUTION COMPUTED TOMOGRAPHY; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; QUANTITATIVE DIAGNOSIS; RISK BENEFIT ANALYSIS; DIAGNOSTIC IMAGING; OBSERVER VARIATION; PROCEDURES; PROGNOSIS; X-RAY COMPUTED TOMOGRAPHY;

BIOMARKERS; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; OBSERVER VARIATION; PROGNOSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 85056492689     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0000000000000507     Document Type: Article

References (59)

1. Richeldi L, Collard HR, Jones MG. Idiopathic pulmonary fibrosis. Lancet 2017; 389:1941-1952.
2. Richeldi L, Costabel U, Selman M, et al. Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. N Engl J Med 2011; 365:1079-1087.
3. Richeldi L, du Bois RM, Raghu G, et al., INPULSIS Trial Investigators. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 2014; 370:2071-2082.
4. King TE Jr, Bradford WZ, Castro-Bernardini S, et al., ASCEND Study Group. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med 2014; 370:2083-2092.
5. Flaherty KR, Thwaite EL, Kazerooni EA, et al. Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax 2003; 58:143-148.
6. Gay SE, Kazerooni EA, Toews GB, et al. Idiopathic pulmonary fibrosis: predicting response to therapy and survival. Am J Respir Crit Care 1998; 157(4 Pt 1):1063-1072.
7. Mogulkoc N, Brutsche MH, Bishop PW, et al. Pulmonary function in idiopathic pulmonary fibrosis and referral for lung transplantation. Am J Respir Crit Care Med 2001; 164:103-108.
8. Lynch DA, Godwin JD, Safrin S, et al., Idiopathic Pulmonary Fibrosis Study Group. High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. Am J Respir Crit Care Med 2005; 172: 488-493.
9. Sumikawa H, Johkoh T, Colby TV, et al. Computed tomography findings in pathological usual interstitial pneumonia: relationship to survival. Am J Respir Crit Care Med 2008; 177:433-439.
10. Wells AU, Hansell DM, Rubens MB, et al. The predictive value of appearances on thin-section computed tomography in fibrosing alveolitis. Am Rev Respir Dis 1993; 148(4 Pt 1):1076-1082.
11. Sundaram B, Gross BH, Martinez FJ, et al. Accuracy of high-resolution CT in the diagnosis of diffuse lung disease: effect of predominance and distribution of findings. AJR. AJR Am J Roentgenol 2008; 191:1032-1039.
12. Goldin J, Elashoff R, Kim HJ, et al. Treatment of scleroderma-interstitial lung disease with cyclophosphamide is associated with less progressive fibrosis on serial thoracic high-resolution CT scan than placebo: findings from the scleroderma lung study. Chest 2009; 136:1333-1340.
13. Akira M, Inoue Y, Arai T, et al. Long-term follow-up high-resolution CT findings in nonspecific interstitial pneumonia. Thorax 2011; 66:61-65.
14. Fujimoto K, Taniguchi H, Johkoh T, et al. Acute exacerbation of idiopathic pulmonary fibrosis: high-resolution CT scores predict mortality. Eur Radiol 2012; 22:83-92.
15. Hansell DM, Bankier AA, MacMahon H, et al. Fleischner Society: glossary of terms for thoracic imaging. Radiology 2008; 246:697-722.
16. Edey AJ, Devaraj AA, Barker RP, et al. Fibrotic idiopathic interstitial pneumonias: HRCT findings that predict mortality. Eur Rad 2011; 21: 1586-1593.
17. Walsh SL, Sverzellati N, Devaraj A, et al. Chronic hypersensitivity pneumonitis: high resolution computed tomography patterns and pulmonary function indices as prognostic determinants. Eur Radiol 2012; 22:1672-1679.
18. Kim EJ, Elicker BM, Maldonado F, et al. Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J 2010; 35:1322-1328.
19. Walsh SL, Sverzellati N, Devaraj A, et al. Connective tissue disease related fibrotic lung disease: high resolution computed tomographic and pulmonary function indices as prognostic determinants. Thorax 2014; 69:216-222.
20. Conti C, Montero-Fernandez A, Borg E, et al. Mucins MUC5B and MUC5AC in distal airways and honeycomb spaces: comparison among idiopathic pulmonary fibrosis/usual interstitial pneumonia, fibrotic nonspecific interstitial pneumonitis, and control lungs. Am J Respir Crit Care Med 2016; 193: 462-464.
21. Piciucchi S, Tomassetti S, Ravaglia C, et al. From 'traction bronchiectasis' to honeycombing in idiopathic pulmonary fibrosis: a spectrum of bronchiolar remodeling also in radiology? BMC Pulm Med 2016; 16:87.
22. Seibold MA, Smith RW, Urbanek C, et al. The idiopathic pulmonary fibrosis honeycomb cyst contains a mucocilary pseudostratified epithelium. PLoS One 2013; 8:e58658.
23. Walsh SL, Wells AU, Sverzellati N, et al. Relationship between fibroblastic focus profusion and high resolution CT morphology in fibrotic lung disease. BMC Med 2015; 241.
24. Salisbury ML, Xia M, Murray S, et al. Predictors of idiopathic pulmonary fibrosis in absence of radiologic honeycombing: a cross sectional analysis in ILD patients undergoing lung tissue sampling. Respir Med 2016; 118: 88-95.
25. Brownell R, Moua T, Henry TS, et al. The use of pretest probability increases the value of high-resolution CT in diagnosing usual interstitial pneumonia. Thorax 2017; 72:424-429.
26. Raghu G, Wells AU, Nicholson AG, et al. Effect of nintedanib in subgroups of idiopathic pulmonary fibrosis by diagnostic criteria. Am J Respir Crit Care Med 2017; 195:78-85.
27. Flaherty KR, Mumford JA, Murray S, et al. Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 2003; 168:543-548.
28. Latsi PI, du Bois RM, Nicholson AG, et al. Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. Am J Respir Crit Care Med 2003; 168:531-537.
29. Akira M, Kozuka T, Yamamoto S, Sakatani M. Computed tomography findings in acute exacerbation of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2008; 178:372-378.
30. Ley B, Ryerson CJ, Vittinghoff E, et al. A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann Intern Med 2012; 156: 684-691.
31. Ley B, Elicker BM, Hartman TE, et al. Idiopathic pulmonary fibrosis: CT and risk of death. Radiology 2014; 273:570-579.
32. Lynch DA, Godwin JD, Safrin S, et al. High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. Am J Respir Crit Care Med 2005; 172:488-493.
33. Edey AJ, Devaraj AA, Barker RP, et al. Fibrotic idiopathic interstitial pneumonias: HRCT findings that predict mortality. Eur Radiol 2011; 21: 1586-1593.
34. Best AC, Lynch AM, Bozic CM, et al. Quantitative CT indexes in idiopathic pulmonary fibrosis: relationship with physiologic impairment. Radiology 2003; 228:407-414.
35. Best AC, Meng J, Lynch AM, et al. Idiopathic pulmonary fibrosis: physiologic tests, quantitative CT indexes, and CT visual scores as predictors of mortality. Radiology 2008; 246:935-940.
36. Ash SY, Harmouche R, Vallejo DL, et al. Densitometric and local histogram based analysis of computed tomography images in patients with idiopathic pulmonary fibrosis. Respir Res 2017; 18:45.
37. Uppaluri R, Hoffman EA, Sonka M, et al. Computer recognition of regional lung disease patterns. Am J Respir Crit Care Med 1999; 160:648-654.
38. Uppaluri R, Hoffman EA, Sonka M, et al. Interstitial lung disease: a quantitative study using the adaptive multiple feature method. Am J Respir Crit Care Med 1999; 159:519-525.
39. Uppaluri R, Mitsa T, Sonka M, et al. Quantification of pulmonary emphysema from lung computed tomography images. Am J Respir Crit Care Med 1997; 156:248-254.
40. Salisbury ML, Lynch DA, van Beek EJ, et al. Idiopathic pulmonary fibrosis: the association between the adaptive multiple features method and fibrosis outcomes. Am J Respir Crit Care Med 2017; 195:921-929.
41. Jacob J, Bartholmai BJ, Rajagopalan S, et al. Evaluation of computer-based computer tomography stratification against outcome models in connective tissue disease-related interstitial lung disease: a patient outcome study. BMC Med 2016; 14:190.
42. Jacob J, Bartholmai BJ, Rajagopalan S, et al. Mortality prediction in IPF: & evaluation of automated computer tomographic analysis with conventional severity measures. Eur Respir J 2017; 49. pii: 1601011. doi: 10.1183/ 13993003.01011-2016. [Epub ahead of print] This article is the first to describe the prognostic significance of 'vessel-related structures, as quantified by the quantitative software tool, CALIPER.
43. Jacob J, Bartholmai BJ, Rajagopalan S, et al. Automated computer-based CT stratification as a predictor of outcome in hypersensitivity pneumonitis. Eur Radiol 2017; 27:3635-3646.
44. Maldonado F, Moua T, Rajagopalan S, et al. Automated quantification of radiological patterns predicts survival in idiopathic pulmonary fibrosis. Eur Respir J 2014; 43:204-212.
45. Jacob J, Bartholmai BJ, Rajagopalan S, et al. Mortality prediction in idiopathic pulmonary fibrosis: evaluation of computer-based CT analysis with conventional severity measures. Eur Respir J 2017; 49:; pii: 1601011.
46. Jacob J, Bartholmai BJ, Rajagopalan S, et al. Unclassifiable-interstitial lung disease: outcome prediction using CT and functional indices. Respir Med 2017; 130:43-51.
47. Tashkin DP, Volkmann ER, Tseng CH, et al. Relationship between quantitative radiographic assessments of interstitial lung disease and physiological and clinical features of systemic sclerosis. Ann Rheum Dis 2016; 75:374-381.
48. Kim HJ, Li G, Gjertson D, et al. Classification of parenchymal abnormality in scleroderma lung using a novel approach to denoise images collected via a multicenter study. Acad Radiol 2008; 15:1004-1016.
49. Kim HJ, Brown MS, Chong D, et al. Comparison of the quantitative CT imaging biomarkers of idiopathic pulmonary fibrosis at baseline and early change with an interval of 7 months. Acad Radiol 2015; 22:70-80.
50. Kim HG, Tashkin DP, Clements PJ, et al. A computer-aided diagnosis system for quantitative scoring of extent of lung fibrosis in scleroderma patients. Clin Exp Rheumatol 2010; 28(5 Suppl 62):S26-S35.
51. Humphries SM, Yagihashi K, Huckleberry J, et al. Idiopathic pulmonary & fibrosis: data-driven textural analysis of extent of fibrosis at baseline and 15-month follow-up. Radiology 2017; 285:270-278. This is the first description of Data-Driven Textural Analysis, which is an unsupervised quantitative CT software package, which provides prognostic information in patients with idiopathic pulmonary fibrosis.
52. Humphries SO, Riordan TG, Sundy JS, et al. Change in CT-derived fibrosis score correlates with lung function progression in a clinical trial population with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2017; 195:A6783.
53. Iwasawa T, Ogura T, Sakai F, et al. CT analysis of the effect of pirfenidone in patients with idiopathic pulmonary fibrosis. Eur J Radiol 2014; 83:32-38.
54. Putman RK, Hatabu H, Araki T, et al., Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators; COPD-Gene Investigators. Association between interstitial lung abnormalities and all-cause mortality. JAMA 2016; 315:672-681.
55. Gulshan V, Peng L, Coram M, et al. Development and validation of a deep learning algorithm for detection of diabetic retinopathy in retinal fundus photographs. JAMA 2016; 316:2402-2410.
56. Esteva A, Kuprel B, Novoa RA, et al. Dermatologist-level classification of skin cancer with deep neural networks. Nature 2017; 542:115-118.
57. Lakhani P, Sundaram B. Deep learning at chest radiography: automated classification of pulmonary tuberculosis by using convolutional neural networks. Radiology 2017; 284:574-582.
58. Yasaka K, Akai H, Abe O, Kiryu S. Deep learning with convolutional neural network for differentiation of liver masses at dynamic contrast-enhanced CT: a preliminary study. Radiology 2017; 286:887-896.
59. Gonzalez G, Ash SY, Vegas-Sanchez-Ferrero G, et al. Disease staging and & prognosis in smokers using deep learning in chest computed tomography. Am J Respir Crit Care Med 2018; 197:193-203. This is the first application of deep learning to chest CT for the purposes of outcome prediction and paves the way for more expansive studies in patients with other lung diseases including lung fibrosis.